SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Zenmark Names Takeda Pharmaceutical Co. Ltd.'s REVESTIVE (teduglutide): a New Drug for the Treatment of Short Bowel Syndrome